Research indicates that in early non-small cell lung cancer, the primary source of IL-17 is tumor-infiltrating γδ T cells, and a higher abundance of γδ T cells has been observed in lymph node metastases of non-small cell lung cancer patients (100). This evidence concerns the gene IL17A and neoplasm.